Advertisement

CNS Drugs

, Volume 32, Issue 12, pp 1185–1185 | Cite as

Correction to: Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain

  • John A. Hey
  • Petr Kocis
  • Jakub Hort
  • Susan Abushakra
  • Aidan Power
  • Martin Vyhnálek
  • Jeremy Y. Yu
  • Martin Tolar
Correction
  • 119 Downloads

1 Correction to: CNS Drugs (2018) 32:849–861  https://doi.org/10.1007/s40263-018-0554-0

Page 856: Fig. 6 was an incorrect duplication of Fig. 5. The correct figure (Fig. 6) is given below.
Fig. 6

Ion-mobility spectrometry–mass spectrometry drift time as a function of mass/charge (m/z) after 24 h of incubation shows the profile of Aβ42 oligomers with 1000-fold excess of 3-sulfopropanoic acid

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • John A. Hey
    • 1
  • Petr Kocis
    • 1
  • Jakub Hort
    • 2
    • 3
  • Susan Abushakra
    • 1
  • Aidan Power
    • 1
  • Martin Vyhnálek
    • 2
    • 3
  • Jeremy Y. Yu
    • 1
  • Martin Tolar
    • 1
  1. 1.Alzheon, IncFraminghamUSA
  2. 2.International Clinical Research CentreSt. Anne’s University Hospital BrnoBrnoCzech Republic
  3. 3.Department of Neurology, Cognitive Center, 2nd Faculty of Medicine, Motol University HospitalCharles UniversityPragueCzech Republic

Personalised recommendations